Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Redback spider antivenom versus placebo for redback spider bite
ACTRN12609000063213Phase 4Completed
- Sponsor
- Calvary Mater Newcastle
- Start
- Jan 2009
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of redback spider antivenom in Redback spider envenomation, sponsored by Calvary Mater Newcastle. Primary endpoints: Clinically significant reduction in pain severity and Resolution of systemic effects. Started Jan 2009; status: completed.
02
Drugs
redback spider antivenom
03
Conditions
Redback spider envenomation
Beyond the preview
Go deeper on ACTRN12609000063213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000063213.